News | October 17, 2025
Secretariat Experts Receive Recognition in Lexology Index Thought Leaders – USA 2026
Secretariat is proud to share that 11 of our experts have been named as USA Thought Leaders in Lexology Index’s 2026 listing.
May 13, 2024
By Richard Manning and Fred Selck
A new class of anti-obesity medications (AOMs) called GLP-1s have been shown to be highly effective at helping people lose weight. Given the efficacy of GLP-1s, and the significant long-term costs associated with treating obesity and its related diseases, there is increasing pressure on public and private health insurers to cover AOMs. This white paper by Richard Manning and Fred Selck finds that when current state market dynamics and assumptions are included in precise financial analytics, treating obesity does not present the threat to Medicare’s financial solvency that other recently published analyses suggest.
Secretariat Experts Receive Recognition in Lexology Index Thought Leaders – USA 2026
Secretariat is proud to share that 11 of our experts have been named as USA Thought Leaders in Lexology Index’s 2026 listing.
87 Secretariat Professionals Named in Lexology Index 2025 Consulting Expert Reports
Secretariat is pleased to share that 87 of our experts have been named in the Lexology Index 2025 Consulting Expert Reports series, achieving recognition as global industry leaders across several key categories.
CPSC Redirects Lithium-Ion Battery Rulemaking for Micromobility Products
Regulatory updates don’t always make headlines, but they can shape the future of industries. The CPSC’s recent procedural move on lithium-ion battery safety for micromobility products is a perfect example. Sam Madden breaks down the latest developments in a short summary.